NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
May 26, 2026 — HeartBeam (NASDAQ: BEAT) develops cable-free, portable 12-lead ECG system to address pre-hospital delay in cardiac care. FDA-cleared for arrhythmia, with heart attack detection planned.
May 26, 2026 — Visory Health promotes Alexandra Robertson to Chief Growth Officer and Brittney Tierce to Chief Technology Officer. The prescription discount card platform expands access to affordable medications for Veterans and underserved communities.
May 26, 2026 — Onco-Innovations reports progress in manufacturing ONC010, a nanoparticle oncology candidate targeting solid tumors. The company advances IND-enabling work with Dalton Pharma Services.
May 26, 2026 — Redwood AI collaborates with Resilience Biosciences to use AI-assisted computational chemistry for non-opioid drug development, aiming to accelerate discovery of safer pain therapies.
May 26, 2026 — A Karolinska Institutet study finds sexual difficulties common among young cancer survivors, varying by cancer type and treatment intensity. CNS Pharmaceuticals works on safer brain cancer drugs. Learn more at TinyGems.
May 26, 2026 — NanoViricides proposes NV-387 for Bundibugyo Ebola strain with no approved treatments. Oral formulation and Phase II trial for mpox may accelerate availability. Learn more about NNVC.
May 26, 2026 — Tonix Pharmaceuticals presents real-world data at ISPOR showing high comorbidity and cost burden of fibromyalgia, as TONMYA launch approaches. Read more at InvestorWire.
May 26, 2026 — Annovis Bio regains NYSE compliance, continuing trading under ANVS. The biotech advances buntanetap for Alzheimer's and Parkinson's diseases, targeting neurotoxic proteins to halt neurodegeneration.
May 26, 2026 — Oncotelic Therapeutics (OTLC) completes $12.5M monetization of N2B CNS delivery system with Lunai Bioworks for Alzheimer's and biodefense. CNS drug delivery breakthroughs drive biotech market opportunities.
May 26, 2026 — GeoVax prioritizes GEO-MVA mpox/smallpox vaccine and Gedeptin cancer therapy, discontinues COVID-19 vaccine. Strategic focus on expedited regulatory paths and commercialization.
May 26, 2026 — Learn how to get affordable dental implants with tips on cost savings, financing, and finding quality care. Compare providers, consider dental schools, and explore payment plans to restore your smile on a budget.
May 25, 2026 — Learn why a diagnosis alone isn't enough for Social Security Disability benefits. Discover Blue Book criteria, Compassionate Allowances, and key evidence needed for approval.
May 25, 2026 — Learn how mental health conditions can qualify for Social Security Disability benefits. Pekas Smith explains the SSA Blue Book's Paragraph B criteria for mental disorders in Arizona.
May 25, 2026 — Learn how SSDI vs SSI choices affect Medicare and AHCCCS eligibility in Arizona. Pekas Smith explains key differences to avoid application delays and secure benefits.
May 25, 2026 — BreastHab rebrands as Thera Rehab Physical and Occupational Therapy in NYC, expanding its scope to include lymphedema therapy, cosmetic recovery, and mastitis treatment while retaining one-to-one care.
May 25, 2026 — Solana Orthodontics in San Antonio offers AI-assisted braces and Invisalign under Dr. Sandra Nairooz, combining personalized care with advanced monitoring for families.
May 23, 2026 — gethair.co.uk launches no shave hair transplant in Ankara, led by Dr. Tayfun Oguzoglu. Discreet restoration lets patients keep hair length, avoiding visible signs of surgery.
May 23, 2026 — True Smile Orthodontics in Liberty Hill TX offers free initial exam for braces and Invisalign. New patients can explore orthodontic care without upfront cost. Learn more.
May 22, 2026 — NeuroOne Medical Technologies restates Q2 2026 results due to revenue overstatement of $0.5M, but reaffirms FY2026 revenue guidance of at least $10.5M. CEO Dave Rosa emphasizes one-time correction.
May 22, 2026 — Helix BioPharma grants 1.3M stock options at $1.63 per share, cancels 2.2M options previously granted. The company advances oncology pipeline with L-DOS47 and GEMCEDA.